Diagnostics at a Crossroads: Navigating IVD Regulation in a Changing Environment

Table Of Contents

Softbound | 256 pages
Edited by Jeffrey N. Gibbs and Allyson B. Mullen

As dramatically illustrated by the COVID-19 pandemic, In Vitro Diagnostics (IVDs) play a central and growing role in the health care system. These products—whether for infectious diseases, cancer, or any other condition—present both opportunities to advance public health and regulatory challenges. FDLI’s practical guidebook, Diagnostics at a Crossroads: Navigating IVD Regulation in a Changing Environment, explores these regulatory issues and provides insights from leading experts on how to address them.

This book covers the key regulatory topics for IVDs, providing both guidance that can help IVD companies succeed and perspectives on critical policy issues. Topics include the history of IVD regulation, regulatory strategies for applicants, pre-market pathways, clinical trials, analytical testing, complying with quality system regulation, post-market regulation, EUAs, complementary and companion diagnostics, LDT, CLIA, EU regulation, and proposed federal legislation.

Containing sixteen chapters written by top practitioners in the field, this book serves as an invaluable single reference for helping to navigate the complex regulatory landscape of in vitro diagnostics.


  • +$30 for nonmembers
  • + $35 to add E-Book or Print at Checkout


  • Transcripts Required
  • +$25 to add E-Book or Print at Checkout


Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

For bookstore bulk pricing, please email [email protected].

Review copies for professors who are adopting a book for a course are available for a reduced fee. Please contact [email protected] for more information.